Evaluation – Scientific Workshop – W051300-B Session Title: Quality Assurance in Clinical Mass Spectrometry – Tools and Metrics to Address Challenges with Sample Preparation, Ion Suppression, Ongoing Validations and Result Analysis Presenters: Danijela Konforte, LifeLabs Denis Orton, Alberta Precision Laboratories Difei Sun, LifeLabs Objectives: At the conclusion of this session, participants will be able to explain and apply: 1. Describe key components of a QA framework for ongoing monitoring of quality in a clinical MS lab, including references to applicable guidelines Select approaches and metrics for ongoing method validations in clinical MS, such as reagent lot-to-lot validations, and validations related to method updates and software upgrades Learn about benefits of automation in sample preparation, data analysis, and tools to track workflow steps Apply a decision-making process to determine when troubleshooting matrix effect is sufficient versus when an assay requires redevelopment Utilize some tips and tricks for method redevelopment based on understanding the source of matrix effects 1. Please rate the Session by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly AgreeSufficient time was allowed for audience participation/active learning. One Two Three Four Five The facilities were satisfactory. One Two Three Four Five The session was free from commercial bias. One Two Three Four Five Overall, I would rate this Symposium as excellent. One Two Three Four Five 2. Please assess the Speaker by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Danijela Konforte, LifeLabsClarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 3. Please assess the Speaker by choosing the appropriate number. Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Denis Orton, Alberta Precision Laboratories Clarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 3. Please asses the Speaker by circling the appropriate number. Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Difei Sun, LifeLabs Clarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 4. As a result of attending this session, I am planning to: (please check one)a) Discuss the session with my colleagues Yes No b) Pursue additional learning activities. Yes No c) Complete a Personal Learning Project. Yes No d) Not change my practice. Yes No 3) Change my practice. Yes No 5. Please explain the change you are planning to make or the learning you plan to complete:6. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply) Medical Expert Communicator Collaborator Manager Health Advocate Scholar Professional 7. General comments about individual speakers8. What topics need to be addressed at future conferences to keep you up to date in your profession?Name Session Title Date Year Location Conference/Event CreditsEmail Session Code
